ECCT Modulates the Therapeutic Landscape for Advanced Lung Adenocarcinoma: A Case Series Demonstrating Efficacy Across EGFR-Mutant and Wild-Type Subtypes
Electro-Capacitive Cancer Therapy (ECCT), a non-invasive electric-field–based treatment used alongside standard therapies, showed meaningful benefits in a case series of six patients with advanced lung adenocarcinoma, including both EGFR-mutant and EGFR-wild-type profiles. Across the cohort, five patients experienced partial tumor response and one achieved stable disease, with imaging demonstrating notable tumor regression and improved clinical